These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11397751)

  • 1. ABC of AIDS. Antiretroviral drugs.
    Weller IV; Williams IG
    BMJ; 2001 Jun; 322(7299):1410-2. PubMed ID: 11397751
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.
    Nicastri E; Sarmati L; d'Ettorre G; Parisi SG; Palmisano L; Montano M; Buonomini AR; Galluzzo C; Vullo V; Concia E; Vella S; Andreoni M
    AIDS Res Hum Retroviruses; 2004 Aug; 20(8):816-8. PubMed ID: 15320985
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can HIV/AIDS be healed with new therapies?].
    Battegay M
    Praxis (Bern 1994); 1997 May; 86(22):931-2. PubMed ID: 9289789
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement in CD4+ cell counts despite persistently detectable HIV load.
    Levitz SM
    N Engl J Med; 1998 Apr; 338(15):1074-5. PubMed ID: 9537882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on the situation of antiretroviral therapy against HIV/AIDS in Henan province based on the CD4+ T cells count and virus load].
    Liu J; Cui WG; Sun GQ; Zhu XP; Tian SA; Sun DY; Yang WJ; Li N; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1013-6. PubMed ID: 21162867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].
    Kuhlmann B; Trein A
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():72-3. PubMed ID: 15373057
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy.
    Kesselring A; Gras L; Smit C; van Twillert G; Verbon A; de Wolf F; Reiss P; Wit F
    Clin Infect Dis; 2011 Jun; 52(12):1458-65. PubMed ID: 21628488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or death.
    Hill AM; DeMasi R; Dawson D
    Antivir Ther; 1998; 3(3):139-45. PubMed ID: 10682131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapeutic possibilities for human immunodeficiency virus/acquired immunodeficiency syndrome.
    Balint GA
    Pharmacol Ther; 2001 Jan; 89(1):17-27. PubMed ID: 11316511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
    Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
    BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
    Persaud D; Palumbo P; Ziemniak C; Chen J; Ray SC; Hughes M; Havens P; Purswani M; Gaur AH; Chadwick EG;
    J Infect Dis; 2007 May; 195(10):1402-10. PubMed ID: 17436219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic strategies in HIV infection-immune reconstitution and virus suppression].
    Herzmann C; Düesberg U; Arastéh K
    Med Klin (Munich); 2004 Jun; 99(6):323-5. PubMed ID: 15221057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
    Spritzler J; Mildvan D; Russo A; Asthana D; Livnat D; Schock B; Kagan J; Landay A; Haas DW;
    Clin Infect Dis; 2003 Aug; 37(4):551-8. PubMed ID: 12905140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.
    Cohen CJ; Andrade-Villanueva J; Clotet B; Fourie J; Johnson MA; Ruxrungtham K; Wu H; Zorrilla C; Crauwels H; Rimsky LT; Vanveggel S; Boven K;
    Lancet; 2011 Jul; 378(9787):229-37. PubMed ID: 21763935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
    Olsen CH; Gatell J; Ledergerber B; Katlama C; Friis-Møller N; Weber J; Horban A; Staszewski S; Lundgren JD; Phillips AN;
    AIDS; 2005 Feb; 19(3):319-30. PubMed ID: 15718843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.
    ; Yeni P; Cooper DA; Aboulker JP; Babiker AG; Carey D; Darbyshire JH; Floridia M; Girard PM; Goodall RL; Hooker MH; Mijch A; Meiffredy V; Salzberger B
    Lancet; 2006 Jul; 368(9532):287-98. PubMed ID: 16860698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questions about HIV causing AIDS? Viral load and T-cell (CD4) counts: why they really matter.
    AIDS Treat News; 2001 May; (364):7-8. PubMed ID: 11569964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.